Imageens 's technogy is based on the gold standard image processing algorithms for measuring Arterial Function by MRI
From its origin, IMAGEENS was plunged in international DeepTech. Founded in 2017, IMAGEENS was created to build market-ready medical image processing software based on DeepTech technologies built over 10 years of technical and clinical research from world-class research institutions such as Sorbonne Université, the APHP, and John Hopkins.
Since its inception, IMAGEENS has demonstrated its ability to leverage advanced AI to build cutting-edge medical software. This innovation has been recognized through several prestigious French innovation competitions (ILAB, PIA, PIA Leader, INSERM Innovation Prize) and multiple innovation labels (Jeune Entreprise Innovante (JEI) and Startup DeepTech).
Today, IMAGEENS is a spearhead company in the rapidly growing field of AI in cardiovascular health. IMAGEENS has the world's most clinically validated technology to analyse arterial function by MRI, and is deploying this technology in combination with other AI components to revolutionize treatment decisions in cardiovascular health.
Imageens' technology story
Imageens technology is based on the gold standard image processing software 'ArtFun' for measuring Arterial Function by MRI.
ArtFun has enabled ~80 top publications, resulting in 1510 citations, used in 7 countries and has been clinically validated in the world famous MESA clinical trial, which obtained data on 4000+ patients over 10 years.
Our clinically-validated MRI image analysis software enables world-class researchers to seamlessly measure arterial stiffness, fluid dynamics, and geometry biomarkers.